Hantech Bio-Technology Co., Ltd.
TWO: 1294.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- CEO
- Yulin Li
- Employees
- 154
- Headquarters
- Yuanlin, Taiwan
- IPO year
- 2022
- Market cap
- NT$2.4B
- Website
- https://www.htbios.com
Loading 1294…
Loading profile data…Frequently asked questions about 1294
What does Hantech Bio-Technology Co., Ltd. (1294.TWO) do?
Hantech Bio-Technology Co., Ltd. develops, manufactures, and sells science-based health products with various eco-friendly pouch styles in Taiwan. It provides dietary supplements in gel, liquid, and powder form under OEM or ODM partnerships. The company offers for its dietary supplements in various packages, such as rectangle, curve, Z, round, w...
Where does 1294.TWO trade?
Hantech Bio-Technology Co., Ltd. (1294.TWO) trades on the Taipei Exchange.
What sector is 1294.TWO in?
Hantech Bio-Technology Co., Ltd. (1294.TWO) operates in the Consumer Defensive sector, specifically in the Packaged Foods industry.
Who is the CEO of Hantech Bio-Technology Co., Ltd.?
Yulin Li is the chief executive officer of Hantech Bio-Technology Co., Ltd. (1294.TWO).
Where is Hantech Bio-Technology Co., Ltd. headquartered?
Hantech Bio-Technology Co., Ltd. is headquartered in Taiwan.
Does 1294.TWO pay a dividend?
Yes — Hantech Bio-Technology Co., Ltd. (1294.TWO) paid a trailing twelve-month dividend of TWD 2.84 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1294.TWO go public?
Hantech Bio-Technology Co., Ltd. (1294.TWO) completed its initial public offering in 2022.